Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free IKT Stock Alerts

Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History

Inhibikase Therapeutics logo
$1.86 -0.04 (-2.11%)
Closing price 04:00 PM Eastern
Extended Trading
$1.86 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Inhibikase Therapeutics Stock Price Performance

The Inhibikase Therapeutics (IKT) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 9.27%. In the past month, the stock has increased 9.41%, reflecting recent market activity.

As of the latest close, Inhibikase Therapeutics traded at $1.90 with a market cap of $250.91 million and volume of 792,462 shares.

Receive IKT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-9.71%
1 Month
Performance
+9.41%
3 Month
Performance
+11.38%
Year-To-Date
Performance
-9.27%

IKT Stock Chart for Thursday, May, 14, 2026

IKT Chart by TradingView

Inhibikase Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026$1.92$1.90
-1.04%		$1.95$1.87792,462 shs$250.91 million
05/12/2026$2.03$1.92
-5.42%		$2.04$1.91592,396 shs$253.56 million
05/11/2026$2.06$2.03
-1.46%		$2.13$2.02504,728 shs$268.08 million
05/08/2026$1.99$2.06
+3.52%		$2.10$1.95945,806 shs$262.81 million
05/07/2026$2.01$1.99
-1.00%		$2.04$1.91796,482 shs$262.80 million
05/06/2026$1.93$2.01
+4.15%		$2.01$1.90668,937 shs$265.45 million
05/05/2026N/A$1.93$1.99$1.91446,510 shs$254.88 million
04/30/2026$1.86$1.89
+1.61%		$1.94$1.86433,682 shs$249.60 million
04/29/2026$1.88$1.86
-1.06%		$1.89$1.83553,457 shs$245.63 million
04/28/2026$1.89$1.88
-0.53%		$1.90$1.84544,065 shs$248.27 million
04/27/2026$1.88$1.89
+0.53%		$1.92$1.85690,404 shs$249.59 million
04/24/2026$1.93$1.88
-2.59%		$1.95$1.86630,650 shs$248.27 million
04/23/2026$1.82$1.93
+6.04%		$1.95$1.791.03 million shs$254.88 million
04/22/2026$1.67$1.82
+8.98%		$1.83$1.66957,000 shs$240.30 million
04/21/2026$1.81$1.67
-7.73%		$1.80$1.632.59 million shs$220.49 million
04/20/2026$1.83$1.81
-1.09%		$1.92$1.761.83 million shs$241.62 million
04/17/2026$1.70$1.83
+7.65%		$1.85$1.721.60 million shs$241.62 million
04/16/2026$1.79$1.70
-5.03%		$1.79$1.67840,199 shs$224.45 million
04/15/2026$1.70$1.79
+5.29%		$1.80$1.691.10 million shs$236.33 million
04/14/2026$1.71$1.70
-0.58%		$1.75$1.691.38 million shs$224.45 million
04/13/2026$1.70$1.71
+0.59%		$1.77$1.68816,112 shs$225.77 million
Related Companies

This page (NASDAQ:IKT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Trump is positioned. Elon lights the fuse.
Bitcoin is back above $80,000. Altcoins are pumping. ETF inflows are accelerating. The CLARITY Act… the most b...
Crypto 101 Media | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel